# Study on Efficacy and Safety of Divaza in Patients With Chronic Cerebral Ischemia and Cognitive Disorders

> **NCT04370028** · — · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 2583 (actual)

## Conditions studied

- Chronic Cerebral Ischemia

## Interventions

- **DRUG:** Divaza

## Key facts

- **NCT ID:** NCT04370028
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 2583 (ACTUAL)
- **Last updated:** 2021-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04370028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04370028, "Study on Efficacy and Safety of Divaza in Patients With Chronic Cerebral Ischemia and Cognitive Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04370028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*